What is the amount of unrealized holding gains (losses) on derivatives reported in 2019? What is the value of short-term investments Pfizer reported in 2019? As it relates to Pfizer’s 2018 annual financial statements, the majority of short-term investments represent investments that are categorized in which portfolio? How much goodwill was recognized upon the acquisition of Medivation in 2016? How much net income was attributable to non-controlling interests in 2019? What is the fair value of available-for-sale debt securities (short-term and long-term combined) as of December 31, 2019? How much equity is attributable to non-controlling interests in 2019? What is the total fair value of derivatives reported as liabilities as of December 31, 2018? What is the gross amount of unrealized holding gains (losses) on available-for-sale securities reported in 2019? Be sure to include reversals of previously recognized unrealized gains/losses for AFS securities that were sold during 2019. The Pfizer, Inc. 2017 Financial report: 1. The short term investments reported by the company for the year 2017 are $ 18,650 million. 2. The majority of the investment portfolio of the company is categorized into available for sale debt and equity securities of $ 17,493 million. 3. The equity attributable to non-controlling interest is $ 348 million for the year 2017. 4. The net income attributable to non-controlling interest is $ 47 million for the year 2017. 5. Goodwill of $ 646 million has been recognized in 2016 upon the acquisition of Anacor Pharmaceuticals. 6. The company recognized gross unrealized holding gain of $ 439 million from available for sale securities. 7. The company recognized unrealized losses on derivatives of $10 million along with reclassification of previously recognized gains for $ 520 million providing for net $ 530 million of other comprehensive losses. 8. The fair value of available for sale securities is $23,757 million as of Dec 31,2017 9. The fair value of derivatives is $691 million as of Dec 31,2017 being reported as liabilities.